CONRAY
Details
- Status
- Prescription
- First Approved
- 1962-08-16
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
CONRAY Approval History
What CONRAY Treats
1 indicationsCONRAY is approved for 1 conditions since its original approval in 1962. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Lesions
CONRAY Boxed Warning
NOT FOR INTRATHECAL USE...
NOT FOR INTRATHECAL USE
Drugs Similar to CONRAY
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CONRAY FDA Label Details
ProIndications & Usage
FDA Label (PDF)Conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. Conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperito...
NOT FOR INTRATHECAL USE...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.